Galmed Pharmaceuticals Ltd..
GLMD.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on developing therapies for liver diseases. Their primary focus is on developing Aramchol, a liver-targeted SCD1 modulator, for the treatment of non-alcoholic steatohepatitis (NASH) and other liver-related conditions. ...Show More
Better Health for All
0
No evidence available to assess Galmed Pharmaceuticals Ltd. on Better Health for All.
Fair Money & Economic Opportunity
0
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. The provided articles do not contain any information related to financial services, lending practices, or economic opportunity initiatives, which are the focus of the 'Fair Money & Economic Opportunity' ethical value.
1
Therefore, no evidence was found to assess the company against any of the defined KPIs.
Fair Pay & Worker Respect
0
No evidence available to assess Galmed Pharmaceuticals Ltd. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Galmed Pharmaceuticals Ltd. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
-40
Galmed Pharmaceuticals Ltd. has a whistleblower policy that explicitly protects whistleblowers from retaliation and provides channels for anonymous reporting.
1
However, there is no evidence regarding independent investigation processes for these reports. The company also has an anti-corruption policy that refers to the FCPA and Israeli Anti-bribery provisions, prohibiting bribes, kickbacks, and improper payments, and requiring prior approval for gifts, meals, travel, and entertainment to government officials.
2
The articles do not provide details on the frequency or effectiveness metrics of anti-corruption training.
Kind to Animals
-60
Galmed Pharmaceuticals engages in animal testing, including in vivo testing in mice and rodents for conditions such as Idiopathic Pulmonary Fibrosis and inflammatory bowel disease.
1
There is no specific evidence of the company having a policy to reduce animal testing or adopting alternatives.
2
While alternatives cover most toxicity and irritation endpoints, lethal assays are still retained.
3
The company uses between 50,000 and 100,000 animals annually, with no transparent reduction targets. The company has research collaboration with Virginia Commonwealth University, which could potentially involve animal studies, but there is no formal collaboration or engagement with animal welfare stakeholders mentioned.
4
No War, No Weapons
0
The provided articles do not contain any specific, concrete data points or explicit statements regarding Galmed Pharmaceuticals Ltd.'s involvement in arms manufacturing, military contracts, dual-use technologies, sales to sanctioned regimes, peacebuilding investments, or any related policies or oversight. Therefore, no KPIs can be scored based on the evidence provided.
Planet-Friendly Business
0
No evidence available to assess Galmed Pharmaceuticals Ltd. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No evidence available to assess Galmed Pharmaceuticals Ltd. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess Galmed Pharmaceuticals Ltd. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, concrete data points for Galmed Pharmaceuticals Ltd. (GLMD.US) related to waste management, product recyclability, packaging sustainability, or any other 'Zero Waste & Sustainable Products' KPIs were found in the provided articles. The articles either discuss other companies' waste reduction efforts (Eaton, GSK)
1
or focus on GLMD.US's drug development, financial filings, or general company information, none of which provide evidence for the specified KPIs.
2